Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Kaletra“
Suchtreffer
Begriffe & Kennungen
Kaletra · 4.5 · 50 The extent of increase depends on dosage adjustment recommendations. the timing of ritonavir Monitor for AD
Eintrag öffnenKaletra · 4.5 · 51 Neratinib Serum concentrations may be Concomitant use of neratinib with increased due to CYP3A Kaletra is c
Eintrag öffnenKaletra · 4.5 · 52 Kaletra must not be administered once daily in combination with phenytoin. Carbamazepine and Carbamazepine:
Eintrag öffnenKaletra · 4.5 · 53 benefit/risk to patient justifies the use of voriconazole. Anti-gout agents Colchicine single dose Colchici
Eintrag öffnenKaletra · 4.5 · 54 Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, i
Eintrag öffnenKaletra · 4.5 · 55 Rifampicin Lopinavir: Co-administration of Kaletra with Large decreases in lopinavir rifampicin is not reco
Eintrag öffnenKaletra · 4.5 · 56 Benzodiazepines Midazolam Oral Midazolam: Kaletra must not be co-administered AUC: ↑ 13-fold with oral mida
Eintrag öffnenKaletra · 4.5 · 57 Inhaled, injectable or Fluticasone propionate, 50 g Greater effects may be expected intranasal fluticasone
Eintrag öffnenKaletra · 4.5 · 58 Ergot alkaloids Dihydroergotamine, Serum concentrations may be Concomitant administration of ergonovine, er
Eintrag öffnenKaletra · 4.5 · 59 Herbal products St John’s wort Lopinavir: Herbal preparations containing St (Hypericum perforatum) Concentr
Eintrag öffnenKaletra · 4.5 · 60 No clinical relevant interaction fluvastatin or pravastatin is expected. recommended. Pravastatin is not me
Eintrag öffnenKaletra · 4.5 · 82 Co-administered drug Effects on drug levels Clinical recommendation by therapeutic area concerning co-admin
Eintrag öffnenKaletra · 4.5 · 83 Maraviroc Maraviroc: The dose of maraviroc should be AUC: ↑ 295% decreased to 150 mg twice daily Cmax: ↑ 97
Eintrag öffnenKaletra · 4.5 · 84 Fentanyl Fentanyl: Careful monitoring of adverse Increased risk of side-effects effects (notably respirator
Eintrag öffnenKaletra · 4.5 · 85 Apalutamide Apalutamide is a moderate to Decreased exposure of Kaletra may strong CYP3A4 inducer and this r
Eintrag öffnenKaletra · 4.5 · 86 Fostamatinib Increase in fostamatinib Co-administration of fostamatinib metabolite R406 exposure. with Kale
Eintrag öffnenKaletra · 4.5 · 87 Rivaroxaban Rivaroxaban: Co-administration of rivaroxaban AUC: ↑ 153% and Kaletra may increase (Ritonavir 6
Eintrag öffnenKaletra · 4.5 · 88 monitoring should be conducted, particularly before and during 2 weeks after starting or stopping Kaletra,
Eintrag öffnenKaletra · 4.5 · 89 Anti-infectives Fusidic acid Fusidic acid: Concomitant administration of Concentrations may be increased Ka
Eintrag öffnenKaletra · 4.5 · 90 Rifabutin, 150 mg QD Rifabutin (parent drug and active When given with Kaletra the 25-O-desacetyl metabolit
Eintrag öffnen